Información del producto
- (2S,3R,3aS,7aR)-2-(1,3-Benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,7a-dimethoxy-3-methyl-5-(2-propen-1-yl)-6(2H)-benzofuranone
- 6(2H)-Benzofuranone, 2-(1,3-benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,7a-dimethoxy-3-methyl-5-(2-propenyl)-, (2S,3R,3aS,7aR)-
- 6(2H)-Benzofuranone, 2-(1,3-benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,7a-dimethoxy-3-methyl-5-(2-propenyl)-, [2S-(2α,3β,3aα,7aα)]-
- 6(2H)-benzofuranone, 2-(1,3-benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,7a-dimethoxy-3-methyl-5-(2-propen-1-yl)-, (2S,3R,3aS,7aR)-
Kadsurin A is a novel, orally bioavailable small molecule that binds to the receptor for FGF-2 and inhibits its function. Kadsurin A has been shown to protect against muscle injury in vivo and in vitro by suppressing the activity of two key enzymes involved in muscle tissue degradation, proteases and cathepsins. Kadsurin A also has potent anti-inflammatory effects that may be due to its ability to inhibit the release of pro-inflammatory cytokines from macrophages. These properties make Kadsurin A a promising therapeutic candidate for treating kidney disease, cardiac disease, and muscle loss due to aging or injuries.
Propiedades químicas
Consulta técnica sobre: 3D-XK178298 Kadsurin A
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
